164 related articles for article (PubMed ID: 27738394)
1. Targeting of the epidermal growth factor receptor with mesoporphyrin IX-peptide conjugates.
Fontenot KR; Ongarora BG; LeBlanc LE; Zhou Z; Jois SD; Vicente MG
J Porphyr Phthalocyanines; 2016 Jan; 20(1-4):352-366. PubMed ID: 27738394
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of BODIPY-Peptide Conjugates for Fluorescence Labeling of EGFR Overexpressing Cells.
Zhao N; Williams TM; Zhou Z; Fronczek FR; Sibrian-Vazquez M; Jois SD; Vicente MGH
Bioconjug Chem; 2017 May; 28(5):1566-1579. PubMed ID: 28414435
[TBL] [Abstract][Full Text] [Related]
3. Targeting EGFR Overexpression at the Surface of Colorectal Cancer Cells by Exploiting Amidated BODIPY-Peptide Conjugates.
Williams TM; Zhou Z; Singh SS; Sibrian-Vazquez M; Jois SD; Henriques Vicente MDG
Photochem Photobiol; 2020 May; 96(3):581-595. PubMed ID: 32086809
[TBL] [Abstract][Full Text] [Related]
4. Click Conjugation of Boron Dipyrromethene (BODIPY) Fluorophores to EGFR-Targeting Linear and Cyclic Peptides.
Williams TM; Kaufman NEM; Zhou Z; Singh SS; Jois SD; Vicente MDGH
Molecules; 2021 Jan; 26(3):. PubMed ID: 33498632
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, Characterization, and Evaluation of Near-IR Boron Dipyrromethene Bioconjugates for Labeling of Adenocarcinomas by Selectively Targeting the Epidermal Growth Factor Receptor.
Kaufman NEM; Meng Q; Griffin KE; Singh SS; Dahal A; Zhou Z; Fronczek FR; Mathis JM; Jois SD; Vicente MGH
J Med Chem; 2019 Apr; 62(7):3323-3335. PubMed ID: 30835998
[TBL] [Abstract][Full Text] [Related]
6. Phthalocyanine-peptide conjugates for epidermal growth factor receptor targeting.
Ongarora BG; Fontenot KR; Hu X; Sehgal I; Satyanarayana-Jois SD; Vicente MG
J Med Chem; 2012 Apr; 55(8):3725-38. PubMed ID: 22468711
[TBL] [Abstract][Full Text] [Related]
7. Molecular dynamics, MMGBSA, and docking studies of natural products conjugated to tumor-targeted peptide for targeting BRAF V600E and MERTK receptors.
Lambo DJ; Lebedenko CG; McCallum PA; Banerjee IA
Mol Divers; 2023 Feb; 27(1):389-423. PubMed ID: 35505173
[TBL] [Abstract][Full Text] [Related]
8. Exploring pitfalls of
Striese F; Sihver W; Gao F; Bergmann R; Walther M; Pietzsch J; Steinbach J; Pietzsch HJ
Amino Acids; 2018 Oct; 50(10):1415-1431. PubMed ID: 30039310
[TBL] [Abstract][Full Text] [Related]
9. Amphiphilic drug-peptide-polymer conjugates based on poly(ethylene glycol) and hyperbranched polyglycerol for epidermal growth factor receptor targeting: the effect of conjugate aggregation on in vitro activity.
Pethő L; Kasza G; Lajkó E; Láng O; Kőhidai L; Iván B; Mező G
Soft Matter; 2020 Jun; 16(24):5759-5769. PubMed ID: 32530018
[TBL] [Abstract][Full Text] [Related]
10. In silico studies of interactions of peptide-conjugated cholesterol metabolites and betulinic acid with EGFR, LDR, and N-terminal fragment of CCKA receptors.
Bashant MM; Mitchell SM; Hart LR; Lebedenko CG; Banerjee IA
J Mol Model; 2021 Dec; 28(1):16. PubMed ID: 34961887
[TBL] [Abstract][Full Text] [Related]
11. EGFR-targeting peptide-coupled platinum(IV) complexes.
Mayr J; Hager S; Koblmüller B; Klose MHM; Holste K; Fischer B; Pelivan K; Berger W; Heffeter P; Kowol CR; Keppler BK
J Biol Inorg Chem; 2017 Jun; 22(4):591-603. PubMed ID: 28405842
[TBL] [Abstract][Full Text] [Related]
12. Enhanced cellular uptake with a cobaltacarborane-porphyrin-HIV-1 Tat 48-60 conjugate.
Sibrian-Vazquez M; Hao E; Jensen TJ; Vicente MG
Bioconjug Chem; 2006; 17(4):928-34. PubMed ID: 16848399
[TBL] [Abstract][Full Text] [Related]
13. Tumor cell targeting of transferrin-PEG-TNF-alpha conjugate via a receptor-mediated delivery system: design, synthesis, and biological evaluation.
Jiang YY; Liu C; Hong MH; Zhu SJ; Pei YY
Bioconjug Chem; 2007; 18(1):41-9. PubMed ID: 17226956
[TBL] [Abstract][Full Text] [Related]
14. The synthesis of 64Cu-chelated porphyrin photosensitizers and their tumor-targeting peptide conjugates for the evaluation of target cell uptake and PET image-based pharmacokinetics of targeted photodynamic therapy agents.
Mukai H; Wada Y; Watanabe Y
Ann Nucl Med; 2013 Aug; 27(7):625-39. PubMed ID: 23605059
[TBL] [Abstract][Full Text] [Related]
15. A computational and laboratory approach for the investigation of interactions of peptide conjugated natural terpenes with EpHA2 receptor.
Goncalves BG; Banerjee IA
J Mol Model; 2023 Jun; 29(7):204. PubMed ID: 37291458
[TBL] [Abstract][Full Text] [Related]
16. A novel small peptide as an epidermal growth factor receptor targeting ligand for nanodelivery in vitro.
Han CY; Yue LL; Tai LY; Zhou L; Li XY; Xing GH; Yang XG; Sun MS; Pan WS
Int J Nanomedicine; 2013; 8():1541-9. PubMed ID: 23626467
[TBL] [Abstract][Full Text] [Related]
17. Selection of Aptamer for N-Methyl Mesoporphyrin IX to Develop Porphyrin Metalation DNAzyme.
Yang L; Cao Y; Pei R
Methods Mol Biol; 2022; 2439():15-26. PubMed ID: 35226312
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, aggregation and cellular investigations of porphyrin-cobaltacarborane conjugates.
Hao E; Sibrian-Vazquez M; Serem W; Garno JC; Fronczek FR; Vicente MG
Chemistry; 2007; 13(32):9035-42. PubMed ID: 17676575
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and properties of cell-targeted Zn(II)-phthalocyanine-peptide conjugates.
Sibrian-Vazquez M; Ortiz J; Nesterova IV; Fernandez-Lazaro F; Sastre-Santos A; Soper SA; Vicente MG
Bioconjug Chem; 2007; 18(2):410-20. PubMed ID: 17279788
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
